Fintel reports that on December 15, 2025, Wells Fargo maintained coverage of CareDx (NasdaqGM:CDNA) with a Equal-Weight ...

Derivatives North America (CDNA) has announced a strategic collaboration with ERShares and Signal Markets to develop a global ...

CareDx (CDNA) has quietly staged a sharp rebound, with shares up roughly 11% over the past week and almost 29% in the past month, drawing fresh attention to its transplant diagnostics business. See ...

Crypto.com partners with DMCC to explore blockchain applications for tokenised commodities, trade settlement, and digital ...

Eva Ados, Chief Investment Strategist and COO of ERShares, added, "As market complexity increases, investors need clearer signals, not more noise. This platform is designed to connect macroeconomic ...

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University's College ...

Detailed price information for Marvell Technology Inc (MRVL-Q) from The Globe and Mail including charting and trades.

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University’s College ...

Wells Fargo analyst Brandon Couillard raised the firm’s price target on CareDx (CDNA) to $18 from $14 and keeps an Equal Weight rating on the ...

Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...

Quantum Computing Inc. ("QCi" or the "Company") , an innovative, quantum optics and integrated photonics technology company, today announced that it has signed an agreement (the "Stock Purchase ...

A new reverse genetics system for norovirus could aid in the development of novel antiviral therapies and vaccines.